News archive

27 September 2021 15:49

Developed a novel, “Soft Rubber Bolus” for radiation therapy - Easily shapable by hand, leading to high-precision irradiation and more adapted treatment -- Kindai University

- Enables shape adjustment on site during treatment which was impossible with conventional tools - Achieves close fitting on uneven parts by shaping easily with heating. Allows for more personalized radiation therapy - Can be disinfected and reused, and easily utilized at multiple medical institutions

26 June 2021 03:30

World’s First! Predicting the effectiveness of Immune Checkpoint Inhibitor. Expected to establish a personalized medical therapy for liver cancer -- Kindai University

- Predicted effectiveness of immune checkpoint inhibitors (ICIs) using a scoring system related to anti-cancer immune conditions

15 June 2021 03:57

World’s First! Identified Begomovirus Resistance Gene in Pepper. Possible solution for global problems: Reduction of damage by plant viruses -- Kindai University

- Identified begomovirus resistance gene in pepper for the first time in the world - Developing a DNA marker reliably determines begomovirus resistance, to enable breeding of a virus-resistant cultivar

9 June 2021 06:46

World’s First! Verified the Efficacy and Safety of Immune Checkpoint Inhibitor “Opdivo” in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function -- Kindai University

Verified the efficacy of immune checkpoint inhibitor (Opdivo) in patients with advanced hepatocellular carcinoma (aHCC) and mild to moderate impairment of liver function (Child-Pugh B class). Kindai University School of Medicine led the international collaborative research for aHCC patients with liver dysfunction for which no treatment options were available before.

7 April 2021 03:05

Developed a new way to generate “Circularly Polarized Luminescence” required for 3D projection Likely to lower manufacturing cost of organic EL panels for 3D display -- Kindai University

Under external magnetic field, circularly polarized luminescence (CPL) was successfully generated from achiral platinum complexes at room temperature. Expected to reduce manufacturing costs of organic EL panels for 3D display, and practical applications for advanced next-generation security/authentication technologies.

22 February 2021 08:13

Developed a highly sensitive measurement system for diagnosis of high-risk prostate cancer. Enabling highly effective and rapid detection of cancer while reducing the burden on patients -- Kindai University

- Measures serum core-type fucosylated PSA, which was not possible in the past, with high speed and high sensitivity - Verified that fucosylated PSA index significantly rises in a man with high-risk prostate cancer - Adjunct in the conventional PSA test, high-risk prostate cancer can be effectively detected

16 February 2021 12:12

Elucidation of the role of "Stress Granules" that can be therapeutic targets for cancer and ALS -- Kindai University

- Discovered for the first time in the world that Stress Granules (SGs) have the role of a "safety brake" that regulates signaling pathways that control cell proliferation, such as Protein Kinase C (PKC) and Mitogen-Activated Protein Kinase (MAPK). - SGs have the function of preventing excessive activation of MAPK by incorporating PKC.

1 February 2021 00:28

Mechanism of the selective induction of cancer cell-specific cell death by ACA-28 - Kindai University

- Elucidation of the mechanism of the compound "ACA-28" that selectively induces cell death in cancer cells - ACA-28 induces cell death of cancer cells and inhibits the growth by destroying tumor suppressor factors. - Expectations for the development of anticancer drugs with less side effects that target brakes instead of accelerators for cancer cells

1 September 2020 00:50

Efficacy of Esophageal Cancer Postoperative Adjuvant Treatment, Peptide Vaccine Treatment, Elucidated 5-year Survival Rate Approx. Doubled for Esophageal Cancer Patients - Kindai University

Kindai University’s Faculty of Medicine has, in a world first, shown the efficacy of cancer-specific vaccine therapy as a postoperative adjuvant therapy in a phase 2 clinical trial. Administration of cancer-specific vaccine therapy roughly doubled the 5-year survival rate of advanced esophageal cancer patients. Vaccine therapy amplifying CTL2 is expected to help validate peptide vaccine therapy.

7 July 2020 05:11

Discovery of Novel Nuclear Structure Inside Fertilized Eggs - Research Results Bring Us Closer to Solving the Riddle of the Development of Animals -- Kindai University

This research is expected to contribute to the development of reproductive medicine, including human infertility treatment, and animal breeding technology through practical application of the special characteristics of fertilized eggs that were discovered.

30 June 2020 01:11

Slack for higher education: Kindai to Become First Japanese University to Invigorate University-wide Communications and Smoothen the Delivery of Online Classes - Kindai University

- Introduction of Slack aims to build a new communication platform for staff and students institution wide - Utilization of Slack enhances the effectiveness of distance learning solutions - Expansion of student support through user-friendly Slack

11 June 2020 08:53

Efficacy of Opdivo (Nivolumab) in Cancer of Unknown Primary Cases Confirmed - Kindai University

- Efficacy of molecular target drug Nivolumab verified in investigator-initiated clinical trial for use with CUP by hospital team from Kindai University’s Faculty of Medicine - Reductions by more than half in tumor size in over 20% of CUP patients observed - Nivolumab expected to become standard treatment for CUP cases with no standard treatment